We have recently cared for an infant with neonatal hypoglycemia secondary to endogenous organic, hyperinsulinism (blood glucose 22mg/dl; insulin 92uU/ml) that was refractory to diazoxide ...

From the Peter Bent Brigham Hospital, Boston, Mass. Derick — Physician, Peter Bent Brigham Hospital. Newton — Senior Associate in Surgery, Peter Bent Brigham Hospital. Schulz — Instructor in ...

The congenital hyperinsulinism market has demonstrated remarkable growth, attributed to increasing awareness, early diagnosis, and the rise of personalized treatments. Valued at USD 194.5 billion in ...

Qatar Foundation member Sidra Medicine has conducted the industry-sponsored ‘sunRIZE’ trial for paediatric congenital hyperinsulinism. The first pharmaceutical trial comes after Sidra launched ...

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Congenital Hyperinsulinism Market" report has been added to ResearchAndMarkets.com's offering. The congenital hyperinsulinism market has demonstrated ...

(NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development of its lead drug candidate, ersodetug, for the treatment of congenital hyperinsulinism ...

"FDA's granting of Orphan Drug Designation is a recognition of the serious unmet need patients with tumor hyperinsulinism face and validates the potential significant benefit that ersodetug can ...